Axios

@axios ↗

Deleted No

Hibernated Yes

Last Checked Oct. 26, 2022

Created

Fri Sep 02 18:43:40 +0000 2022

Likes

Retweets

Source

Twitter Web App

View Raw Data

JSON Data

View on Twitter

Likely Available

Axios @axios

Research in Clinical Infectious Diseases found the drug remains effective for vaccinated people who contract COVID-19, reducing emergency room visits by lowering the risk of complications like lower respiratory tract infection and cardiac arrhythmia. https://t.co/fxiAnLSFZh — PolitiTweet.org

Posted Sept. 2, 2022 Hibernated

Preceded By

Axios @axios

The CDC recommends Paxlovid for those over the age of 50, and for those with medical conditions like lung or heart disease that makes them high-risk, although the drug's emergency authorization covers anyone 12 years old and up. https://t.co/fxiAnLSFZh — PolitiTweet.org

Posted Sept. 2, 2022 Hibernated

Followed By

Axios @axios

Beyond the Pfizer study requested by the FDA, a clinical trial of immunocompromised people is evaluating if Paxlovid should be used for five, 10 or 15 days. https://t.co/fxiAnLSFZh — PolitiTweet.org

Posted Sept. 2, 2022 Hibernated